Should I buy Veeva Systems (VEEV) stock or is it too late?

Veeva Systems · Health Care · price $302

See the full Veeva Systems (VEEV) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: BMO Capital — 73% of its targets hit on this sector (240 calls tested). It aims for $270 (-10 %), call made on August 28, 2026, maturing on August 28, 2027 (47 d ago).

The 16 reliable analysts $287-5.0 %

The 4 other firms $323+6.9 %

How to read it: the 16 reliable firms are not filtered by optimism — 5 aim above the price, 11 below, hence their $287 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Veeva Systems

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Canaccord Genuity	88 %	+52.6 %	8	$260 -14%
Guggenheim	67 %	+40.5 %	6	$310 +3%
Stifel	68 %	+34.6 %	19	$275 -9%
Morgan Stanley	75 %	+31.3 %	32	$275 -9%
Baird	62 %	+23.9 %	16	$300 -1%
Piper Sandler	65 %	+15.6 %	26	$320 +6%
Goldman Sachs	83 %	+13.5 %	6	$165 -45%
Needham	58 %	+8.4 %	26	$310 +3%

In short — Should you invest in Veeva Systems? Is it too late, still worth it? Analysts are fairly positive (65% buy, median target $295, i.e. -2%), and the most reliable on VEEV targets even higher. But the valuation is stretched (P/E ~49), it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

65% of analysts rate it a buy (Buy consensus, 20 ratings) — a sign of market conviction.
The most reliable firm on VEEV, BTIG (100% hit rate, 2 scored calls), targets $340 (call made on June 4, 2026, maturing on June 4, 2027) (+13%) in its most recent call.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 20 ratings, 6 are neutral and 1 is a sell.
Limited upside: the median target is only -2% from the current price.
High valuation (P/E ~49): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on VEEV

Median target $295 (-2%) · 20 ratings · Buy consensus

Strong Buy00%

Buy1365%

Hold630%

Sell15%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Veeva Systems now?

We won't decide for you. The facts: 65% of analysts rate it a buy, median target $295 (-2%), and BTIG (most reliable on VEEV, 100%) targets $340. Weigh that against valuation (P/E ~49). This is not personalized advice.

Is it too late to invest in Veeva Systems?

The stated upside is small: the median target ($295) sits just -2% from the price ($302) (most reliable on VEEV: BTIG, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Veeva Systems still worth investing in?

It depends on the gap between the price ($302) and its estimated value: analysts target $295 on median (-2%), with 65% buys (most reliable on VEEV: BTIG, 100%). Cross-check with their real reliability on VEEV and the cautions above. Information, not advice.

What's the main risk in buying VEEV?

The consensus is not unanimous: of 20 ratings, 6 are neutral and 1 is a sell.

→ Go deeper: the full Veeva Systems profile (consensus, analyst reliability, price target, performance).